ATE423135T1 - Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten - Google Patents

Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten

Info

Publication number
ATE423135T1
ATE423135T1 AT05012643T AT05012643T ATE423135T1 AT E423135 T1 ATE423135 T1 AT E423135T1 AT 05012643 T AT05012643 T AT 05012643T AT 05012643 T AT05012643 T AT 05012643T AT E423135 T1 ATE423135 T1 AT E423135T1
Authority
AT
Austria
Prior art keywords
treatment
neurodegenerative diseases
loop
ngf
ngf activity
Prior art date
Application number
AT05012643T
Other languages
English (en)
Inventor
Luigi Vitagliano
Laura Zaccaro
Giancarlo Morelli
Enzo Martegani
Original Assignee
Primm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Primm Srl filed Critical Primm Srl
Application granted granted Critical
Publication of ATE423135T1 publication Critical patent/ATE423135T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05012643T 2005-06-13 2005-06-13 Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten ATE423135T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05012643A EP1734052B1 (de) 2005-06-13 2005-06-13 Heterodimere Peptide mit NGF Aktivität und deren Verwendung zur Behandlung von neurodegenerativen Krankheiten

Publications (1)

Publication Number Publication Date
ATE423135T1 true ATE423135T1 (de) 2009-03-15

Family

ID=35276556

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05012643T ATE423135T1 (de) 2005-06-13 2005-06-13 Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten

Country Status (5)

Country Link
US (1) US8461110B2 (de)
EP (2) EP1734052B1 (de)
AT (1) ATE423135T1 (de)
DE (1) DE602005012812D1 (de)
WO (1) WO2006133853A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006318550A1 (en) * 2005-11-22 2007-05-31 Mcgill University Intraocular pressure-regulated early genes and uses thereof
EP1921087A1 (de) * 2006-11-10 2008-05-14 Primm S.R.L. Verfahren zur Herstellung von cyclischen Peptiden
WO2008070513A1 (en) * 2006-12-01 2008-06-12 Alcon Research, Ltd. Modulation of polysialylated neural adhesion molecules (psa-ncam) as a regulator of ocular disease
EP2099468B1 (de) * 2006-12-05 2018-07-11 The Royal Institution for the Advancement of Learning/McGill University Verfahren zur verwendung von trk-rezeptormodulatoren
ITRM20070119A1 (it) * 2007-03-08 2008-09-09 Inbios S R L Udo del ngf per la preparazione di mendicamenti per la cura della gliosi reattiva
BRPI0821383A2 (pt) * 2007-12-20 2015-06-16 Cytos Biotechnology Ag Conjugados de ngf e usos dos mesmos
JP5480242B2 (ja) 2008-04-04 2014-04-23 マイムトジェン ファーマシューティカルズ インコーポレイテッド ドライアイ治療用βターンペプチド模倣環式化合物
EP2400977B1 (de) 2009-02-27 2014-07-23 Mimetogen Pharmaceuticals Inc. Peptidomimetische zyklische verbindungen zur behandlung von retinitis pigmentosa
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US9067988B2 (en) 2010-12-01 2015-06-30 Alderbio Holdings Llc Methods of preventing or treating pain using anti-NGF antibodies
US9783601B2 (en) 2010-12-01 2017-10-10 Alderbio Holdings Llc Methods of preventing inflammation and treating pain using anti-NGF compositions
US9078878B2 (en) 2010-12-01 2015-07-14 Alderbio Holdings Llc Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
US9539324B2 (en) 2010-12-01 2017-01-10 Alderbio Holdings, Llc Methods of preventing inflammation and treating pain using anti-NGF compositions
ES2834125T3 (es) * 2012-06-22 2021-06-16 Mimetogen Pharmaceuticals Inc Síntesis de compuestos cíclicos peptidomiméticos de giro beta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity

Also Published As

Publication number Publication date
DE602005012812D1 (de) 2009-04-02
US8461110B2 (en) 2013-06-11
US20090318335A1 (en) 2009-12-24
WO2006133853A1 (en) 2006-12-21
EP1891099A1 (de) 2008-02-27
EP1734052A1 (de) 2006-12-20
EP1734052B1 (de) 2009-02-18

Similar Documents

Publication Publication Date Title
ATE423135T1 (de) Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten
BRPI0514115A (pt) terapia de combinação empregando-se proteìnas de fusão de transferrina compreendendo glp-1
AR021448A1 (es) Metodo para producir un polipeptido quimerico
DK1877435T4 (da) Glucagon-lignende-peptid-2 (glp-2)-analoger
CY1113850T1 (el) Νεα παραγωγα ινσουλινης
DE60223058D1 (de) Zusammensetzungen und verfahren zur behandlung von diabetes
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
WO2007047829A3 (en) Novel heterodimeric proteins and uses thereof
ATE540980T1 (de) Proteinkomplex mit immunglobulinfragment und verfahren zu dessen herstellung
ATE525082T1 (de) Compstatin-analoga mit verbesserter wirkung
PL1873166T3 (pl) Ulepszone dimery sgp 130Fc
ATE542920T1 (de) Modifiziertes menschliches wachstumshormon
MX2008012748A (es) Un proceso para la concentracion de un polipeptido.
ATE346095T1 (de) Glycoprotein vi - fc fusions protein zur behandlung von gefässerkrankungen
CY1114619T1 (el) Συνθετικα αναλογα πεπτιδιων νευρικης αναγεννησης
IS6072A (is) Æðasamloðunar sameindir og mótun á starfsemi þeirra
NZ562436A (en) Toll-like receptor 14 (TLR14) and use thereof
CY1106070T1 (el) Πολυμορφισμοι στο γονιδιο c μεταφορας οργανικου ανιοντος ανθρωπου (oatp-c) - (organic anion transporter c gene)
DE602004019701D1 (de) Peptide welche an Apo2L (Trail) Rezeptoren binden und Verwendungen davon
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
DE602005014990D1 (de) Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
ATE360644T1 (de) Vegf-peptide und deren verwendung
GEP20084464B (en) Mutated neublastin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties